| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000014543 |
| Receipt No. | R000016909 |
| Official scientific title of the study | The investigation of the association of low-dose aspirin and reflux esophagitis |
| Date of disclosure of the study information | 2014/07/14 |
| Last modified on | 2017/07/17 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | The investigation of the association of low-dose aspirin and reflux esophagitis | |
| Title of the study (Brief title) | The investigation of the association of low-dose aspirin and reflux esophagitis | |
| Region |
|
|
| Condition | ||
| Condition | Reflux esophagitis | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The aim of this study is to investigate whether low-dose aspirin is related to reflux esophagitis and to evaluate treatment response of proton pump inhibitor for reflux esophagitis patients |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | The risk odds ratio of the low-dose aspirin for the reflux esophagitis onset |
| Key secondary outcomes | The rate that reflux esophagitis improves by proton pump inhibitor administration |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | We let reflux esophagitis patients take esomeprazole 20mg/day for 8 weeks
|
|
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | The patients who diagnosed as reflux esophagitis, Los Angeles classification, grade A, B, C, or D, by esophagogastroduodenoscopy
|
|||
| Key exclusion criteria | 1. Patients with active gastric ulcer or duodenal ulcer.
2. Patients with hypersensitivity to esomeprazole. 3. Patients in the administration of atazanavir sulfate or a Rirupibirin hydrochloride. 4. Patients with chronic alcoholism or drug dependence. 5. Patients with warning symptoms, such as vomitting, or sudden weight loss. 6. The patient who has difficulty in participation in this examination by the mergers such as a serious liver disease, renal disease, or heart trouble. 7. Pregnant women, nursing girls or the women who may be pregnant. 8. Patients who judged unsuitable for research participation. |
|||
| Target sample size | 200 | |||
| Research contact person | |
| Name of lead principal investigator | Kazuhiro Mizukami |
| Organization | Oita university |
| Division name | Department of Gastroenterology |
| Address | 1-1, Idaigaoka, Hasama, Yufu, Oita |
| TEL | 097-586-6193 |
| mizkaz0809@oita-u.ac.jp | |
| Public contact | |
| Name of contact person | Kazuhiro Mizukami |
| Organization | Oita university |
| Division name | Department of Gastroenterology |
| Address | 1-1, Idaigaoka, Hasama, Yufu, Oita |
| TEL | 097-586-6193 |
| Homepage URL | |
| mizkaz0809@oita-u.ac.jp | |
| Sponsor | |
| Institute | Oita university, department of Gastroenterology |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Non-profit Organization for Promotion of Gastrointestinal Disease Treatment Research |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000016909 |